USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Alcon Inc.

USPTO PatentsView assignee record - 793 granted patents across 107 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

793

Total patents granted

107

CPC technology areas

15.0

Avg claims per patent

+79100%

5-year filing velocity

The verdict

Alcon holds 793 US patents across 107 technology areas, rank #567 of 50,000 tracked assignees.

#567
of 50,000 US assignees by volume: Top 1%
by Innovation Score (67.4/100): 15.0
avg claims per patent: +79100%
filing velocity, last 5 yrs

Portfolio overview

Alcon Inc. has been granted 793 US utility patents between 2015 and 2025, placing Alcon Inc. at rank #567 across all assignees tracked by PlainPatent. This portfolio spans 107 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.0 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a Foreign Corporation, Alcon Inc. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Alcon sits between B/e Aerospace, Inc. (801 patents, rank #563) and Abbott Diabetes CARE Inc. (788 patents, rank #571) - the closest US assignees by grant volume. The composite Innovation Score of 67.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 792 grants, compared with 1 in the 2015–2019 window, a +79100% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Alcon Inc.'s 15.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a diversified footprint across 100+ CPC subclasses spreads risk across many technology fronts. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Alcon Inc. against peers pursuing similar technology classes.

B/E Aerospace

801
Fortinet

801
Resmed Pty

800
Wipro

794
Alcon ◀

793
Bally Gaming

792
Gentex

790
YETI Coolers

789
Abbott Diabetes C…

788

What this shows Alcon holds 793 patents at rank #567, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Alcon

By rank, the assignees closest to #567 in granted patent volume.

Leaders in A61F (Filters Implantable INTO Blood Vessels)

Other assignees with the most granted patents in Alcon's primary technology class.

Alcon's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

67 Top 1% higher than 99% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Alcon Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	0.1%
2020	109	13.7%
2021	144	18.2%
2022	123	15.5%
2023	134	16.9%
2024	134	16.9%
2025	148	18.7%

Which technologies does Alcon Inc. patent most?

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 489

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 348

G02B - OPTICAL ELEMENTS, SYSTEMS OR APPARATUS 198

B29D - PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE 114

G02C - SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES 107

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 65

G06T - IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 62

C08L - COMPOSITIONS OF MACROMOLECULAR COMPOUNDS 48

B29K - INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR ; MOULDS, ; REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS 47

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 42

C08F - MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS 41

C08G - MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS 40

B29C - SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING 36

H04N - PICTORIAL COMMUNICATION, e.g. TELEVISION 33

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 31

Top 15 of 107 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Diversified

Claim Depth Standard

Velocity Accelerating

Where it ranks

Overall rank by patents

#567

Across all tracked assignees

Innovation Score

67.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Alcon Inc. hold?

Alcon Inc. holds 793 US granted patents filed between 2015 and 2025, spanning 107 technology areas.

What is Alcon Inc.'s Innovation Score?

Alcon Inc. has an Innovation Score of 67.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Alcon Inc. focus on?

Alcon Inc.'s top technology area is A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS) with 489 patents. The company has filed patents in 107 CPC subclasses total.

Is Alcon Inc.'s patent filing rate increasing or decreasing?

Alcon Inc.'s recent filing velocity is +79100% compared to the prior five-year period. This indicates accelerating innovation.

What does claim depth mean for Alcon Inc.'s patents?

Alcon Inc.'s patents average 15.0 claims each. This falls within the standard range, providing solid legal coverage.

How is the Alcon Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Alcon's 793 grants land it in the top 1% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Alcon ranks #567 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61F - see who else leads that technology area. A61F leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.